The present invention relates to novel methods for preferentially activating and expanding NK cells. The methods utilize the stimulatory effects of IL-15 and CD137 ligand to preferentially expand and activate NK cells in a mixed cell culture comprising NK cells.

 
Web www.patentalert.com

< Monoclonal antibody and hybridoma producing the same

> Microcapsules

~ 00468